Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes
- PMID: 33214924
- PMCID: PMC7642631
- DOI: 10.21037/jtd-cus-2020-006
Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes
Abstract
Chronic obstructive pulmonary disease (COPD) causes load-capacity-drive imbalance in both wakefulness and sleep, principally driven by expiratory flow limitation and hyperinflation. Sleep imposes additional burdens to the respiratory muscle pump, driven by changes in respiratory muscle tone, neural respiratory drive and consequences of the supine position. COPD patients are therefore at higher risk of decompensation during sleep, which may manifest as altered sleep architecture, isolated nocturnal desaturation, sleep hypoventilation and restless legs. Each form of sleep disordered breathing in COPD is associated with adverse clinical and patient-reported outcomes, including increased risk of exacerbations, hospitalisation, cardiovascular events, reduced survival and poorer quality of life. COPD-obstructive sleep apnoea (OSA) overlap syndrome represents a distinct clinical diagnosis, in which clinical outcomes are significantly worse than in either disease alone, including increased mortality, risk of cardiovascular events, hospitalisation and exacerbation frequency. Sleep disordered breathing is under-recognised by COPD patients and their clinicians, however early diagnosis and management is crucial to reduce the risk of adverse clinical outcomes. In this narrative review, we describe the pathophysiology of COPD and physiological changes that occur during sleep, manifestations and diagnosis of sleep disordered breathing in COPD and associated clinical outcomes.
Keywords: COPD-obstructive sleep apnoea (OSA) overlap; Chronic obstructive pulmonary disease (COPD); pulmonary mechanics; respiratory physiology; sleep; sleep disordered breathing.
2020 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (Available at http://dx.doi.org/10.21037/jtd-cus-2020-006). The series “5th Clinical Update Sleep” was commissioned by the editorial office without any funding or sponsorship. JS served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Journal of Thoracic Disease. PBM reports grants and personal fees from Philips, grants and personal fees from ResMed, grants and personal fees from F&P, grants and personal fees from B&D Electromedical, personal fees from Santhera, grants from GSK, outside the submitted work. The authors have no other conflicts of interest to declare.
Figures





References
-
- World Health Organisation. Projections of mortality and causes of death, 2016 and 2060. Accessed 5th May 2020. Available online: http://www.who.int/healthinfo/global_burden_disease/projections/en/
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources